Document is current
Any future updates will be listed below
-
Authors
Könsgen, Nadja
Hauprich, Julia
Wahlen, Sarah
Hellbrecht, Irma
Becker, Monika
Bühn, Stefanie
Meyer, Nora
Blödt, Susanne
Carl, Günther
Follmann, Markus
Frenz, Stefanie
Langer, Thomas
Nothacker, Monika
Schaefer, Corinna
Pieper, Dawid
Breuing, Jessica
-
Funding
Funding for this research was provided by:
Private Universität Witten/Herdecke gGmbH
- License Information
-
More Information
Article History
Received: 27 November 2023
Accepted: 26 August 2024
First Online: 3 September 2024
Declarations
:
: This study was part of the AnImPaLLO project that was approved by the University Witten/Herdecke Ethics Committee (160/2021). All procedures were performed in accordance with the principles of the Declaration of Helsinki. Written informed consent was obtained from all the participants.
: Not applicable.
: MB was involved in the development of patient versions of clinical practice guidelines (PVGs) of oncology in Germany. SBl and MN are representatives of the AWMF, which receives constant financial support from the GGPO and is involved in methodological counselling for clinical practice guidelines (CPGs) in oncology and other CPGs. MF is a representative publisher of PVGs in oncology in Germany and is involved in the methodological counselling of CPGs and PVGs in oncology. TL is a representative publisher of PVGs of oncology in Germany. CS was involved in the development of PVGs in oncology in Germany until 2019 and is responsible for the development of PVGs of the National Program for Disease Management Guidelines (NDMG) and their methodological refinement. All other authors declare no conflict of interest.
